Families who lost children after kratom use, alongside addiction recovery advocates and physicians, are speaking out across the United States to warn consumers about the severe health risks of over-the-counter kratom products. As these botanical and concentrated products fuel a billion-dollar domestic industry and gain political backers in Washington, public health officials and toxicologists report that compounds found in the plant act on opioid receptors in the brain, creating significant risks of physical dependence, withdrawal, and fatal overdose.

Derived from Mitragyna speciosa, a tree native to Southeast Asia classified in the same botanical family as coffee, kratom is legally sold in most U.S. states. Products ranging from loose leaf powders and capsules to gummies, liquid shots, and concentrated tablets are widely accessible online and at tens of thousands of gas stations, convenience stores, and smoke shops.

According to CBS News, the Centers for Disease Control and Prevention (CDC) detected kratom in more than 5,000 overdose deaths between 2020 and 2024, prompting urgent calls from bereaved parents and medical professionals for clearer public warnings and tighter federal oversight.

Personal Tragedies Behind a Billion-Dollar Market

Much of the public confusion surrounding kratom stems from how it is marketed. The American Kratom Association, a consumer advocacy and lobbying group, describes natural kratom as a safe food used as an herbal supplement for energy and general wellbeing. However, families who spoke with CBS News reported that their sons began taking the substance under the impression that it was a harmless alternative to caffeine or alcohol, only to suffer fatal consequences.

Susan Eppard told the network that her son, Matthew, believed kratom was similar to coffee before he collapsed suddenly and died while playing cards with friends.

Wendy Chamberlain shared that her son, Joe, started taking kratom for an energy boost after a friend told him it was safer than an energy drink. According to post-mortem findings cited in the report, the deaths of both Matthew Eppard and Joe Chamberlain were attributed solely to mitragynine, the main active alkaloid in kratom. Two other young men profiled, Daniel Bregger and Wyatt Wheeler, died from causes that included mitragynine combined with prescription or over-the-counter medications.

Beyond fatal overdoses, everyday consumers have reported rapid onset of physical dependence from retail drinks. In a separate CBS News report, Michigan resident Melanie Clark described purchasing a plant-based tonic called Feel Free—priced at roughly $10 a bottle at local gas stations and corner markets—after seeing social media advertisements targeting tired mothers.

Hoping to ease postpartum depression and fatigue, she noted that within three weeks of starting the drink, she needed multiple bottles just to get through the day.

Advocates who have lived through dependence are also trying to educate the public. Hilary Tesluck, the 30-year-old executive director of the advocacy group End Kratom Addiction, recently detailed her own history of dependence and recovery with Fox News to highlight the warning signs that consumers often miss when taking legal retail supplements.

How Kratom and Concentrated 7-OH Affect the Body

Estimates of how many Americans consume kratom vary widely, ranging from more than 5 million lifetime users to estimates as high as 15 million cited by David Epstein, a senior investigator at the National Institute on Drug Abuse (NIDA) Intramural Research Program, according to NPR. A 2021 study referenced by the Cleveland Clinic found that more than 1 in 200 U.S.

adults had used kratom in the previous year, with higher rates among men, adults aged 18 to 49, and individuals with a history of depression or substance use disorder.

While the kratom plant contains more than 40 known alkaloids, medical researchers focus primarily on two active compounds: mitragynine and 7-hydroxymitragynine, commonly known as 7-OH. In an article for the Cleveland Clinic, emergency physician Dr. John R. Queen explained that mitragynine is more abundant in the raw leaf, producing stimulant effects at lower doses via serotonergic activity and mild sedation and pain relief at higher doses through partial activation of the brain's mu-opioid receptors.

By contrast, 7-OH occurs naturally in the plant in only trace amounts, yet it exhibits much stronger activity at the mu-opioid receptor. In recent years, manufacturers have begun selling highly concentrated or semi-synthetic 7-OH tablets, gummies, tonics, and chocolates.

Dr. Andrew Kolodny, medical director for the Opioid Policy Research Collaborative at Brandeis University, warned that the effects produced by kratom compounds closely mirror those of traditional opioids like oxycodone, heroin, and fentanyl.

The rise of concentrated 7-OH products has trapped even those who previously used traditional kratom leaf without severe complications. According to NPR, a 38-year-old Michigan man named Tyler used traditional kratom leaf powder in his 20s to stop using illicit opioids and remained off opioids for a decade. In early 2025, he switched to gas-station 7-OH tablets because the raw powders bothered his stomach. Within 18 months, he developed a severe dependence on the potent tablets and required medical sedation in a rapid detox program to survive the withdrawal symptoms.

Interpreting Overdose Data and Regulatory Conflicts

As calls for regulation grow, scientists, federal agencies, and advocacy groups are locked in a complex debate over how to interpret mortality data and where to draw legal boundaries.

The U.S. Food and Drug Administration (FDA), which first issued an import alert aimed at stopping kratom shipments in 2014, warns consumers not to use kratom products because of the risk of liver toxicity, seizures, and substance use disorder.

Forensic specialists emphasize that kratom-related fatalities have risen sharply alongside retail availability. Justin Brower, a toxicologist at the forensic testing facility NMS Labs outside Philadelphia, stated that fatal cases linked to kratom have increased roughly tenfold since 2014, noting that he has analyzed thousands of deaths involving the substance, with dozens attributed solely to kratom with no other drugs present.

At the same time, public health data show that many kratom-associated fatalities involve polysubstance use, which complicates both emergency room diagnoses and policy debates. While CDC surveillance detected kratom in more than 5,000 overdose deaths from 2020 to 2024, detection alone does not prove that kratom was the sole cause of death in every instance.

An earlier 2019 CDC analysis of 152 kratom-positive overdose deaths found that medical examiners listed kratom as a contributing cause in 91 cases, while only seven cases detected kratom as the single substance present.

This distinction lies at the heart of the regulatory conflict in Washington. Supporters of tighter restrictions, including bereaved parents and addiction physicians, argue that widespread retail access to opioid-acting compounds poses an unacceptable public health hazard. Meanwhile, industry lobbyists and some policy commentators referenced in a Pain News Network commentary argue that sweeping bans on natural leaf kratom could carry unintended consequences, potentially driving people who use whole-leaf kratom for chronic pain or opioid harm reduction into abrupt withdrawal or back toward illicit street opioids.

While federal officials have weighed targeted restrictions aimed specifically at concentrated 7-OH products, strong public opposition and organized advocacy have stalled past federal efforts to restrict kratom over the last decade.

What Consumers Should Know: Symptoms and Warning Signs

Because over-the-counter kratom and 7-OH products are not FDA-approved medicines, package labels often fail to disclose accurate alkaloid concentrations, serving sizes, or clear dependency warnings. Emergency physicians note that patients frequently do not realize they are consuming a substance that acts on opioid receptors, and standard hospital toxicology screens do not routinely test for mitragynine unless specialized forensic testing is ordered.

What are the signs of acute kratom toxicity and withdrawal?

According to clinical guidance from the Cleveland Clinic, individuals experiencing an acute adverse reaction to kratom may display agitation, rapid heart rate (tachycardia), confusion, extreme drowsiness, or vomiting. More severe reactions reported by federal health agencies include seizures and acute liver injury. Any of these acute symptoms warrant immediate emergency medical evaluation.

For regular users, interrupting or stopping kratom or 7-OH use can trigger both psychological and physical withdrawal.

Psychological symptoms commonly include heightened anxiety, depressed mood, irritability, intense cravings, and restlessness. Physical withdrawal symptoms closely resemble classic opioid withdrawal, presenting as muscle aches, joint pain, diarrhea, abdominal cramping, runny nose, watery eyes, and frequent yawning.

How should someone safely stop using kratom?

Medical specialists advise against abruptly stopping heavy use of kratom or concentrated 7-OH without clinical support, as severe withdrawal can increase the risk of relapse or medical complications. Individuals struggling to control their use should consult a primary care physician or an addiction medicine specialist, who can provide supervised tapering protocols, symptom management medications, or standard treatments used for opioid use disorder.

Sources